BeOne Medicines (ONC) Free Cash Flow (QoQ) (2015 - 2026)
Powered by 
Analysis
BeOne Medicines (ONC) Free Cash Flow (QoQ) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.42 Bn | 131.57 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.59 Bn | 77.60 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.43 Bn | 58.25 Bn | 1.37 Bn |
| 4 | Moderna | 57.61 Bn | 52.47 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 43.97 Bn | 43.97 Bn | - |
| 6 | BeOne Medicines | 40.03 Bn | 34.94 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.33 Bn | 32.02 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.46 Bn | 27.62 Bn | - |
| 9 | Insmed | 27.33 Bn | 26.17 Bn | 358.27 Mn |
| 10 | Incyte | 25.57 Bn | 21.03 Bn | 1.57 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 176.94% |
| Mar 31, 2026 | -58.38% |
| Dec 31, 2025 | 7.15% |
| Sep 30, 2025 | 58.69% |
| Jun 30, 2025 | 1,502.40% |
| Mar 31, 2025 | 8.04% |
| Dec 31, 2024 | -131.66% |
| Sep 30, 2024 | 126.62% |
| Jun 30, 2024 | 55.81% |
| Mar 31, 2024 | -22.86% |
| Dec 31, 2023 | -60.40% |
| Sep 30, 2023 | 43.17% |
| Jun 30, 2023 | 39.75% |
| Mar 31, 2023 | -56.83% |
| Dec 31, 2022 | 34.45% |
| Sep 30, 2022 | -62.50% |
| Jun 30, 2022 | -37.87% |
| Mar 31, 2022 | 51.94% |
| Dec 31, 2021 | -10.67% |
| Sep 30, 2021 | -22.66% |